Loading news...
Pro Medicus Limited (OTCMKTS:PMCUF - Get Free Report)'s stock price traded down 4% on Tuesday. The company traded as low as $143.03 and last traded at $143.03. 45 shares changed hands during trading, a decline of 92% from the average session volume of 561 shares. The stock had previously closed at $148.96. Pro Medicus
Pro Medicus Limited (OTCPK:PMDIY) Shareholder/Analyst Call November 23, 2025 6:00 PM EST Company Participants Peter Kempen Sam Hupert - Co-Founder, CEO, MD & Executive Director Danny English - Financial Controller & Company Secretary Anthony Glenning Conference Call Participants Stewart Burn Conversation Peter Kempen Well, good morning, everybody. On behalf of my fellow directors, I'd like to welcome you to the Annual General Meeting of Pro Medicus Limited, and thank you again for taking the time to be with us today.
Pro Medicus Limited (OTCPK:PMCUF) Q4 2025 Earnings Conference Call August 13, 2025 9:00 PM ET Company Participants Clayton James Hatch - Chief Financial Officer Sam Aaron Hupert - Co-Founder, CEO, MD & Executive Director Conference Call Participants Andrew Paine - CLSA Limited, Research Division Annabel Li - Goldman Sachs Group, Inc., Research Division Christine Trinh - Macquarie Research David A. Low - JPMorgan Chase & Co, Research Division Garry Sherriff - RBC Capital Markets, Research Division John Hester - Bell Potter Securities Limited, Research Division Josh Charles Kannourakis - Barrenjoey Markets Pty Limited, Research Division Mathieu Chevrier - Citigroup Inc., Research Division Operator Thank you for standing by, and welcome to the Pro Medicus Limited Full Year Results Briefing.
Pro Medicus Limited (OTCPK:PMCUF) Q2 2025 Results Conference Call February 12, 2025 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Conference Call Participants Garry Sherriff - RBC Annabel Li - Goldman Sachs Josh Kannourakis - Barrenjoey David Low - JPMorgan Andrew Paine - CLSA Julian Mulcahy – E&P Wei Sim - Jefferies Sarah Mann - Moelis Australia Peter Meichelboeck - Select Equities Christine Trinh - Macquarie Bank Sam Hupert Thank you, and good morning, everybody. Thanks for joining us.
Pro Medicus Limited (OTCPK:PMCUF) Q4 2024 Earnings Conference Call August 13, 2024 9:00 PM ET Company Participants Sam Hupert - CEO Clayton Hatch - CFO Conference Call Participants Garry Sherriff - RBC Annabel Li - Goldman Sachs David Low - JPMorgan Josh Kannourakis - Barrenjoey Andrew Paine - CLSA Melissa Benson - Wilsons Advisory David Bailey - Macquarie Peter Meichelboeck - Select Equities Sarah Mann - Moelis Australia Operator Thank you for standing by, and welcome to the Pro Medicus Limited Full Year Results Briefing. All participants are in a listen-only mode.
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (OTCPK:PMCUF) Q4 2023 Earnings Conference Call August 14, 2023 9:00 PM ET Company Participants Sam Hupert - CEO Clayton Hatch - CFO Conference Call Participants Gary Sherriff - RBC Josh Kannourakis - Barrenjoey Melissa Benson - Wilsons Wei Sim - Jefferies Julian Mulcahy - E&P Sarah Mann - MA Moelis Australia Peter Meichelboeck - Select Equities Operator Thank you for standing by. And welcome to the Pro Medicus Ltd.
Pro Medicus Limited (OTCPK:PMCUF) Q2 2023 Earnings Conference Call February 14, 2023 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Conference Call Participants Gary Sherriff - RBC Josh Kannourakis - Barrenjoey Melissa Benson - Wilsons Andrew Paine - CLSA Mathieu Chevrier - Citigroup Sarah Mann - Moelis Australia Peter Meichelboeck - Select Equities Curtis Larson - Norse Capital Claude Walker - A Rich Life Prasad Patkar - Platypus Iain Wilkie - Morgans Financial Operator Thank you for standing by. Welcome to the Pro Medicus Half Year Results Briefing.
Pro Medicus Limited (OTCPK:PMCUF) Q4 2022 Earnings Conference Call August 17, 2022 9:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Financial Officer and Company Secretary Conference Call Participants Chris Cooper - Goldman Sachs Josh Kannourakis - Barrenjoey Garry Sherriff - Royal Bank of Canada Melissa Benson - Wilsons Julian McCaulkey - E&P Sarah Mann - Moelis Australia Mathieu Chevrier - Citi Operator Thank you for standing by and welcome to the Pro Medicus Full Year Results Briefing. All participants are in a listen-only mode.
ro Medicus Limited (OTCPK:PMCUF) Q2 2022 Earnings Conference Call February 15, 2022 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Financial Officer Conference Call Participants Bosco Feng - Goldman Sachs Josh Kannourakis - Barrenjoey Garry Sherriff - RBC Sarah Mann - Moelis Mathieu Chevrier - Citi Julian Mulcahy - E&P Operator Thank you for standing by. And welcome to the Pro Medicus PME Half Year Results Briefing.
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript